Supplements for people with anxiety
Evidence-graded picks for adults dealing with situational, generalised, or stress-related anxiety, alongside CBT and (where prescribed) medication.
The anxiety stack — rationale by ingredient
Ashwagandha (KSM-66) 300 mg twice daily — for chronic perceived stress
Multiple RCTs show 18–28% reduction in perceived stress scale scores and meaningful cortisol reductions at 300–600 mg/day. Use a standardised extract (KSM-66 or Sensoril). Recent hepatotoxicity case reports mean it should not be assumed risk-free; avoid in pregnancy, active liver disease, or alongside heavy alcohol use. Plan a 1–2 week break every 8–12 weeks.
Magnesium glycinate 300–400 mg elemental nightly
The 2017 Boyle systematic review supports magnesium for subjective anxiety. The glycinate form is well tolerated and pairs nicely with sleep. Particularly useful when anxiety has a somatic component (muscle tension, restless sleep).
L-Theanine 200 mg, as-needed for situational anxiety
Calming without sedation; effective within 30–60 minutes. Useful for performance anxiety, pre-meeting jitters, or any acute trigger. Stack with caffeine for a smoother focus profile. Not effective for chronic generalised anxiety as monotherapy.
Saffron 30 mg/day of a standardised extract (affron, Satiereal)
Saffron has trials showing efficacy comparable to low-dose fluoxetine for mild-to-moderate depression with anxiety. The 30 mg dose is the standard trial dose; doses much higher than 1.5 g have toxicity concerns.
Omega-3 EPA/DHA 2 g/day
The 2018 Su meta-analysis found modest anxiolytic effect of omega-3 across diverse populations, with higher effect at higher EPA-dominant doses. Foundational cardiovascular and mental-health adjunct.
Lemon balm or passionflower as gentle adjuncts
Lemon balm for daytime calmness (300 mg twice daily), passionflower for pre-procedural or bedtime use (250–500 mg). Both are well-tolerated and have small RCT signals. Use when the heavier-evidence options are not appropriate or as adjuncts.
Glycine 3 g at bedtime for sleep-onset anxiety
Cheap, well-evidenced for subjective sleep quality, and pairs with magnesium for the bedtime layer.
What to skip — or use with extreme caution
- Kava extracts — once the leading single-supplement anxiety pick, but the CDC has recorded a meaningful increase in poisoning calls; hepatotoxicity case-series have accumulated. Banned or restricted in multiple European countries. Not recommended as a default.
- CBD without a prescribed indication — claims for anxiety outpace evidence; product quality varies dramatically; can interact with prescription medications.
- GABA capsules — does not cross the blood-brain barrier appreciably; mostly placebo.
- Phenibut — a GABA-B agonist with significant dependence and withdrawal potential. Banned or restricted in several countries. Avoid.
- "Calm" gummies with proprietary blends — typically sub-therapeutic doses of multiple ingredients.
- St John's wort while on SSRIs — serotonin syndrome risk; CYP450 interactions with many prescription drugs.
- 5-HTP combined with serotonergic medications — serotonin syndrome risk; not recommended for routine use.
Sources
- Boyle NB, et al. The effects of magnesium supplementation on subjective anxiety and stress — a systematic review. Nutrients. 2017;9(5):429. PMID: 28445426
- Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. PMID: 31517876
- Hidese S, et al. Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. Nutrients. 2019;11(10):2362. PMID: 31623400
- Lopresti AL, et al. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol. 2014;29(6):517–527. PMID: 25384672
- Su KP, et al. Association of use of omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: a systematic review and meta-analysis. JAMA Netw Open. 2018;1(5):e182327. PMID: 30646157
- Akhondzadeh S, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363–367. PMID: 11679026